Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Medical treatment options for ocular myasthenia gravis.

Authors
Type
Published Article
Journal
Current opinion in ophthalmology
Publication Date
Volume
19
Issue
6
Pages
468–478
Identifiers
DOI: 10.1097/ICU.0b013e328310da18
PMID: 18854691
Source
Medline
License
Unknown

Abstract

Currently, limited evidence favors the use of corticosteroids, azathioprine, and mycophenolate mofetil in ocular myasthenia gravis. There is a need for rigorous clinical trials on the efficacy and safety of these medical therapeutic options in improving ocular symptoms and decreasing the risk of developing generalized myasthenia gravis. Studies on emerging immunomodulators that dampen autoreactivity without affecting general immunity should be pursued.

Statistics

Seen <100 times